GET THE APP

Inhibition of protein kinase CK2 ameliorates EAE by regulating Th | 49394

Primary Health Care: Open Access

ISSN - 2167-1079

Inhibition of protein kinase CK2 ameliorates EAE by regulating Th17/Treg cell development

9th Asia Pacific Global Summit on Healthcare & Immunology

July 03-05, 2017 Kuala Lumpur, Malaysia

Sung Woong Jang and Gap Ryol Lee

Sogang University, South Korea

Posters & Accepted Abstracts: Primary Health Care

Abstract :

Autoimmune diseases are controlled by the balance between T helper 17 (Th17) cells, which promote inflammatory reactions, and regulatory T (Treg) cells, which suppress effector T cells. However, the molecular mechanisms underlying this balance are unclear. Here, we showed that casein kinase 2 (CK2) is a critical determinant of the Th17/Treg cell development. Inhibition of CK2 with a specific inhibitor, CX-4945, and shRNA-mediated knockdown both suppressed Th17 cell differentiation but reciprocally promoted Treg cell differentiation in vitro. Moreover, orally treated CX-4945 ameliorated symptoms of experimental autoimmune encephalomyelitis (EAE) and inhibited Th17 cell infiltration into the central nervous system (CNS). Mechanistically, CX-4945 blocked the IL-6/STAT3 and Akt/mTOR signaling pathways.

Biography :

Sung Woong Jang is a Graduate student of Sogang University, Seoul, Korea and is studying CD4 T cell differentiation in Molecular Immunology Lab of Sogang University, under Prof. Gap Ryol Lee.

Email: swjang@sogang.ac.kr

Top